Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

News and commentary from the endocrinology world ...

Muscle loss is common among people taking GLP-1 medications. Full-body strength training can help preserve muscle mass and ...

Experts from AMCP discuss the real-world evidence on GLP-1 usage and health care spending. In this Q&A, Urick discusses the ...

BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has successfully completed production of its largest ...

The results seen with Foundayo, also known as orforglipron, enabled Lilly’s late-stage Achieve-4 study to hit its primary ...

The FDA loosening and rollback of the Category 2 classification is a direct unlock for Hims’ peptide expansion, including its ...

A 2026 overview of Found Health's GLP-1 medication access model, free online insurance coverage check, disclosed pricing for Wegovy, Zepbound, Ozempic, and compounded semaglutide options, telehealth ...

When it comes to body weight, overall dietary intake matters more than specific timing. People who follow high-fiber diets ...

Biohaven Ltd. downgraded after FDA CRL for troriluzole; see its pipeline shift to obesity/neurology, Phase 2 catalysts, and ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?